Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4394-4398, Vol. 75, No. 9
Applied Tumor Virology Unit F0100 and
Institut National de la Santé et de la Recherche Médicale U
375, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany
Received 14 December 2000/Accepted 6 February 2001
Autonomous parvovirus minute virus of mice (MVM) DNA replication is
strictly dependent on cellular factors expressed during the S phase of
the cell cycle. Here we report that MVM DNA replication proceeds in
specific nuclear structures termed autonomous parvovirus-associated replication bodies, where components of the basic cellular replication machinery accumulate. The presence of DNA polymerases Autonomous parvoviruses and other
members of the Parvoviridae family are unique among animal
viruses in having linear single-stranded DNA genomes. The termini of
their approximately 5,000-nucleotide genomes contain palindromic
sequences which fold into stable hairpin structures and serve as
primers for viral DNA synthesis. The replicative cycle, which takes
place in the nucleus, is initiated by the synthesis of the cDNA strand
leading to the formation of double-stranded replicative-form DNA. This
reaction, also known as conversion, is exclusively dependent on
cellular factors. In addition, the subsequent amplification reactions
require the activity of the virus-encoded major nonstructural protein
NS1 (7).
Several cellular factors which are essential for DNA replication of the
prototype autonomous parvovirus minute virus of mice (MVM) have been
identified through cell fractionation and complementation assays in
vitro replication systems (5, 8, 20). However, very little
is known about the subnuclear organization of MVM DNA replication in
vivo. In contrast to viruses with double-stranded DNA genomes that
replicate in close proximity to preformed nuclear structures known as
promyelocytic leukemia (PML) bodies (for review see reference
18), autonomous parvovirus H-1 was shown to induce characteristic nuclear structures, termed H-1 parvovirus-associated replication (PAR) bodies, which are unrelated to PML bodies
(9). Similar structures were also characterized in
Aleutian mink disease virus-infected cells (21, 22). In
this study, we aimed to determine whether MVM also establishes PAR
body-like structures in the nuclei of infected cells and to analyze the
subnuclear distribution of cellular factors assumed to be involved in
MVM DNA replication in vivo. To this end, A9 mouse cells were infected with MVMp at a multiplicity of infection of 10 PFU per cell. At 15 h postinfection, cells were labeled for 20 min with bromodeoxyuridine (BrdU) at a concentration of 10 µM and then immediately fixed in 1%
formaldehyde for 10 min at room temperature. BrdU incorporation into
replicated viral DNA was detected with a BrdU-specific antibody (Becton
Dickinson) without prior denaturation, thus excluding the detection of
chromosomal DNA replication (21). Simultaneously, NS1 was
detected with the NS1-specific SP8 antibody (11). Analysis by confocal microscopy (LSM510 UV; Zeiss, Jena, Germany) revealed the
accumulation of NS1 in specific nuclear bodies (Fig.
1a) which were also found to be the sites
of ongoing viral DNA replication, as indicated by BrdU incorporation
(Fig. 1b and c). At this time postinfection, no signs of virus-induced
cytotoxicity were visible (Fig. 1d). From these data, we concluded that
MVM DNA replication proceeds in specific nuclear structures similar to
the ones previously described for other autonomous parvoviruses
(9, 21, 22). We would therefore like to propose the more
general term autonomous PAR (APAR) bodies for these virus-induced
structures.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.9.4394-4398.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vivo Accumulation of Cyclin A and Cellular
Replication Factors in Autonomous Parvovirus Minute Virus of
Mice-Associated Replication Bodies
![]()
ABSTRACT
Top
Abstract
Text
References
and
in
these bodies suggests that MVM utilizes partially preformed cellular
replication complexes for its replication. The recruitment of cyclin A
points to a role for this cell cycle factor in MVM DNA replication
beyond its involvement in activating the conversion of virion
single-stranded DNA to the duplex replicative form.
![]()
TEXT
Top
Abstract
Text
References

View larger version (31K):
[in a new window]
FIG. 1.
MVM DNA replication colocalizes with NS1 in APAR bodies
in the nuclei of infected A9 cells. Representative confocal optical
sections through the nuclei of infected cells are shown. NS1 was
localized with the SP8 polyclonal antiserum and a fluorescein
isothiocyanate (FITC)-conjugated secondary antibody (a). Replication
was monitored by incorporation of BrdU and indirect immunofluorescence
using a BrdU-specific antibody and a tetramethyl rhodamine
isothiocyanate (TRITC)-conjugated secondary antibody (b). In a merged
image, colocalized structures from panels a and b appear yellow (c). By
phase-contrast microscopy (Nomarski), the cells show no obvious sign of
NS1-induced cytotoxicity at the time of fixation (15 h postinfection)
(d).
MVM DNA replication starts only after host cells enter the S phase of
the cell cycle. Recently, it was shown that in vitro the conversion
reaction is activated by the cell cycle factor cyclin A, whose
production is induced at the G1/S transition
(1). Cyclin A is involved in the regulation of the S and
G2 phases (25) and has been reported to be
required for chromosomal (16) and simian virus 40 (10, 12) DNA replication. In order to test whether cyclin
A is present in APAR bodies, we performed double immunofluorescence
labeling and confocal microscopical analysis of MVM-infected A9 cells.
Cyclin A, which is homogeneously distributed throughout the nuclei of
mock-infected cells and absent from nucleoli (reference 2
and data not shown), was indeed found to massively accumulate together
with NS1 in the APAR bodies of infected cells (Fig. 2a to
c). Even if one assumes that the subnuclear location at which the conversion reaction takes place predetermines the site of APAR body formation, a sole role for cyclin A
in the conversion reaction is difficult to reconcile with such a strong
accumulation of cyclin A in APAR bodies at 15 h postinfection,
when conversion is thought to be complete. This result could indicate
that the continuous presence of cyclin A is also required for
subsequent NS1-dependent replicative steps. One can furthermore
speculate that the sequestration of this factor is responsible for the
previously described parvovirus-induced cell cycle arrest (23,
24) because deprivation of cyclin A may lead to a failure of
cdk1 activation in the G2 phase, thus preventing cell cycle
progression.
|
Besides cyclin A, cyclin E is involved in the regulation of the G1/S transition and is known to play a role in chromosomal DNA replication (14, 16). In contrast to cyclin A, however, cyclin E did not accumulate in APAR bodies (Fig. 2d to f). Since the cyclin E-specific antibody best recognized the human protein, in these experiments we infected human NBE cells and verified that MVMp indeed induces the formation of APAR bodies in this human cell line, as detected by NS1-specific (Fig. 2d) and BrdU-specific (data not shown) antibodies. The failure to detect an accumulation of cyclin E does not exclude the presence of minute amounts, of this factor in APAR bodies. Our data are, however, in agreement with recent in vitro experiments showing no contribution of cyclin E or cdk2 in the initiation of conversion (1).
Cyclin A forms an active complex with cdk2 at the beginning of the S phase. This complex is assumed to be involved in the regulation of DNA replication, since both cyclin A and cdk2 were found to be associated with replication foci in mammalian cells (3) as well as with replicating DNA in the simian virus 40 in vitro replication system (13). We therefore attempted to detect cdk2 in APAR bodies. Using several different cdk2-specific antibodies, cdk2 could not be shown to accumulate in APAR bodies (Fig. 2g to i). The observed accumulation of cyclin A in APAR bodies (Fig. 2b) would then point to a structural role for cyclin A in these bodies, independent of complex formation with cdk2. However, it is still possible that only catalytic amounts too small to be detected by the method used here are required for MVM DNA replication in APAR bodies.
Parvovirus DNA replication proceeds according to a
leading-strand-synthesis mechanism and has been shown to be dependent
on proliferating cell nuclear antigen (PCNA) in vitro (5).
These and other lines of evidence point to DNA polymerase
as the
enzyme responsible for parvovirus DNA replication (6).
Here, we show that DNA polymerase
indeed accumulates in APAR bodies
in MVM-infected NBE cells (Fig. 3a to c)
and therefore at the sites of ongoing MVM DNA replication. DNA
polymerase
requires for processive DNA synthesis the presence of
the cofactor PCNA, which is also involved in other processes, like DNA
recombination and repair (15). PCNA is distributed
throughout the nucleus except the nucleoli, but it specifically
accumulates in the APAR bodies of MVM-infected NBE cells (Fig. 3d to
f). This finding corroborates earlier in vitro data demonstrating that
PCNA is indispensable for MVM DNA replication (1, 5).
|
The single-strand-DNA-binding protein replication protein A (RPA) is required for MVM DNA replication in vitro (5) and cannot be replaced by other proteins with single-strand-DNA-binding activity (J. Christensen, personal communication). Furthermore, a direct interaction between the 70-kDa subunit of RPA and NS1 was demonstrated in vitro (4). In agreement with these in vitro findings we have observed that RPA massively accumulates at the sites of ongoing parvovirus DNA replication in infected cells (Fig. 3g to i), which strongly suggests its involvement in this process in vivo.
Surprisingly, DNA polymerase
was also found at the sites of MVM DNA
replication (Fig. 3j to l). So far, there is no evidence for a
contribution of DNA polymerase
to parvovirus DNA replication, since
neutralizing antibodies against this enzyme do not impair viral DNA
replication in vitro (5, 19). Furthermore, the presence of
preformed hairpin primers makes a DNA polymerase
-dependent primase
activity dispensable. However, it was shown that DNA polymerase
can
be isolated together with DNA polymerase
and the PCNA loading
factor, replication factor C, from mammalian cells as a stable complex
that is replication competent when template DNA, PCNA, and nucleotides
are added (17). It could be demonstrated that in this
complex, DNA polymerase
is active on single-stranded-DNA templates
only when primer synthesis is a precondition for replication. On a
primer-template junction, as present in parvovirus DNA, the DNA-binding
affinity of replication factor C is higher than that of DNA polymerase
, thereby rendering the latter inactive (17, 27). Since
DNA polymerase
is required for chromosomal DNA replication, it is
tempting to speculate that MVM utilizes cellular replication complexes
that are at least partially preformed, exploiting only the DNA
polymerase
activity and thus evading the need for an
energy-consuming dissociation of preformed cellular complexes. This
would again highlight the opportunistic and minimalistic strategies
used by these viruses.
In summary, the data presented here show for the first time the
formation of APAR bodies in MVM-infected cells and the accumulation of
various cellular replication factors in these structures. Our data
support the idea that the basic cellular replication machinery is used
by MVM for viral DNA replication, including DNA polymerase
, PCNA,
RPA, and cyclin A. DNA polymerase
, which is part of the cellular
replication machinery, was unexpectedly found to accumulate in APAR
bodies but is most likely not active in parvovirus DNA replication. For
cyclin A, it will be of interest to identify the role this factor plays
in parvovirus DNA replication, in addition to its role in the
activation of the conversion reaction in vitro.
| |
ACKNOWLEDGMENTS |
|---|
We acknowledge the generous gift of antibodies from D. Pintel and
N. Salomé (University of Missouri
Columbia) and antiserum from
M. Pagano (New York University, New York, N.Y.). The expert support of
H. Spring (DKFZ, Heidelberg, Germany) with acquisition of data by
confocal microscopy is gratefully acknowledged.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Applied Tumor Virology, Abteilung F0100 and INSERM U 375, Deutsches Krebsforschungszentrum, Postfach 101949, 69009 Heidelberg, Germany. Phone: 49 6221 424977. Fax: 49 6221 424962. E-mail: C.Cziepluch{at}dkfz-heidelberg.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bashir, T.,
R. Horlein,
J. Rommelaere, and K. Willwand.
2000.
Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: a parvovirus DNA replication model.
Proc. Natl. Acad. Sci. USA
97:5522-5527 |
| 2. | Brenot-Bosc, F., S. Gupta, R. L. Margolis, and R. Fotedar. 1995. Changes in the subcellular localization of replication initiation proteins and cell cycle proteins during G1-to S-phase transition in mammalian cells. Chromosoma 103:517-527[Medline]. |
| 3. | Cardoso, M. C., H. Leonhardt, and B. Nadal-Ginard. 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979-992[CrossRef][Medline]. |
| 4. | Christensen, J. 2000. Binding of the major non-structural protein (NS1) of MVM to the large subunit of human replication protein is involved in origin unwinding. Infect. Dis. Rev. 2:152. |
| 5. | Christensen, J., S. F. Cotmore, and P. Tattersall. 1997. A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptide to initiate parvovirus DNA replication. J. Virol. 71:1405-1416[Abstract]. |
| 6. | Cossons, N., E. A. Faust, and M. Zannis-Hadjopoulos. 1996. DNA polymerase delta-dependent formation of a hairpin structure at the 5' terminal palindrome of the minute virus of mice genome. Virology 216:258-264[CrossRef][Medline]. |
| 7. | Cotmore, S. F., and P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:91-174[Medline]. |
| 8. |
Cotmore, S. F., and P. Tattersall.
1998.
High-mobility group 1/2 proteins are essential for initiating rolling-circle-type DNA replication at a parvovirus hairpin origin.
J. Virol.
72:8477-8484 |
| 9. |
Cziepluch, C.,
S. Lampel,
A. Grewenig,
C. Grund,
P. Lichter, and J. Rommelaere.
2000.
H-1 parvovirus-associated replication bodies: a distinct virus-induced nuclear structure.
J. Virol.
74:4807-4815 |
| 10. |
D'Urso, G.,
R. L. Marraccino,
D. R. Marshak, and J. M. Roberts.
1990.
Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase.
Science
250:786-791 |
| 11. | Faisst, S., S. R. Faisst, T. Dupressoir, S. Plaza, A. Pujol, J.-C. Jauniaux, S. L. Rhode, and J. Rommelaere. 1995. Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells. J. Virol. 69:4538-4543[Abstract]. |
| 12. |
Fotedar, A.,
D. Cannella,
P. Fitzgerald,
T. Rousselle,
S. Gupta,
M. Doree, and R. Fotedar.
1996.
Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts.
J. Biol. Chem.
271:31627-31637 |
| 13. |
Fotedar, R., and J. M. Roberts.
1991.
Association of p34cdc with replicating DNA.
Cold Spring Harbor Symp. Quant. Biol.
56:325-333 |
| 14. |
Jackson, P. K.,
S. Chevalier,
M. Philippe, and M. W. Kirschner.
1995.
Early events in DNA replication require cyclin E and are blocked by p21CIP1.
J. Cell Biol.
130:755-769 |
| 15. | Jonsson, Z. O., and U. Hubscher. 1997. Proliferating cell nuclear antigen: more than a clamp for DNA polymerases. Bioessays 19:967-975[CrossRef][Medline]. |
| 16. | Krude, T., M. Jackman, J. Pines, and R. A. Laskey. 1997. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88:109-119[CrossRef][Medline]. |
| 17. | Maga, G., and U. Hubscher. 1996. DNA replication machinery: functional characterization of a complex containing DNA polymerase alpha, DNA polymerase delta, and replication factor C suggests an asymmetric DNA polymerase dimer. Biochemistry 35:5764-5777[CrossRef][Medline]. |
| 18. | Maul, G. G. 1998. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20:660-667[CrossRef][Medline]. |
| 19. |
Ni, T.-H.,
W. F. McDonald,
I. Zolotukhin,
T. Melendy,
S. Waga,
B. Stillman, and N. Muzyczka.
1998.
Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection.
J. Virol.
72:2777-2787 |
| 20. |
Nüesch, J. P. F.,
S. Dettwiler,
R. Corbau, and J. Rommelaere.
1998.
Replicative functions of minute virus of mice NS1 protein are regulated in vitro by phosphorylation through protein kinase C.
J. Virol.
72:9966-9977 |
| 21. | Oleksiewicz, M. B., F. Costello, M. Huhtanen, J. B. Wolfinbarger, S. Alexandersen, and M. E. Bloom. 1996. Subcellular localization of Aleutian mink disease parvovirus proteins and DNA during permissive infection of Crandell feline kidney cells. J. Virol. 70:3242-3247[Abstract]. |
| 22. | Oleksiewicz, M. B., J. B. Wolfinbarger, and M. E. Bloom. 1998. A comparison between permissive and restricted infections with Aleutian mink disease parvovirus (ADV): characterization of the viral protein composition at nuclear sites of virus replication. Virus Res. 56:41-51[CrossRef][Medline]. |
| 23. | Op De Beeck, A., F. Anouja, S. Mousset, J. Rommelaere, and P. Caillet-Fauquet. 1995. The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2. Cell Growth Differ. 6:781-787[Abstract]. |
| 24. | Op De Beeck, A., and P. Caillet-Fauquet. 1997. The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin? J. Virol. 71:5323-5329[Abstract]. |
| 25. | Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971[Medline]. |
| 26. |
Tanaka, S.,
S. Z. Hu,
T. S. Wang, and D. Korn.
1982.
Preparation and preliminary characterization of monoclonal antibodies against human DNA polymerase alpha.
J. Biol. Chem.
257:8386-8390 |
| 27. |
Tsurimoto, T., and B. Stillman.
1991.
Replication factors required for SV40 DNA replication in vitro. I. DNA structure-specific recognition of a primer-template junction by eukaryotic DNA polymerases and their accessory proteins.
J. Biol. Chem.
266:1950-1960 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»